Levels of transforming growth factor beta-1 (TGF-β1) and interleukin 1 beta (IL-1β) in in negative control group (NC), diabetic group (DM), diabetic groups treated with different doses of protein C activator (PCA), and positive control diabetic group treated with metformin (PC). This evidence concerns the gene TGFB1 and diabetes mellitus.